Ken Griffin Agenus Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $653,235 - $1.18 Million	1,036,882 Added 2275.01%	1,082,459 $898,000
Q3 2023 Nov 14, 2023	SELL	$1.12 - $1.88 $6.76 Million - $11.3 Million	-6,031,462 Reduced 99.25%	45,577 $51,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $2.04 $2.98 Million - $4.64 Million	-2,275,554 Reduced 27.24%	6,077,039 $9.72 Million
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $10.6 Million - $21.6 Million	7,310,847 Added 701.79%	8,352,593 $12.7 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $1.19 Million - $1.91 Million	586,707 Added 128.94%	1,041,746 $2.5 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $783,762 - $1.26 Million	399,879 Added 724.94%	455,039 $933,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $576,063 - $1.17 Million	-443,126 Reduced 88.93%	55,160 $107,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $205,274 - $303,107	87,351 Added 21.26%	498,286 $1.23 Million
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $851,945 - $1.67 Million	-291,762 Reduced 41.52%	410,935 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $1.43 Million - $1.91 Million	287,523 Added 69.25%	702,697 $3.69 Million
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $700,405 - $1.5 Million	273,596 Added 193.25%	415,174 $2.28 Million
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $113,418 - $221,355	42,163 Added 42.41%	141,578 $385,000
Q4 2020 Feb 16, 2021	SELL	$3.17 - $4.49 $562,316 - $796,467	-177,387 Reduced 64.08%	99,415 $316,000
Q3 2020 Nov 16, 2020	SELL	$2.98 - $5.2 $1.88 Million - $3.28 Million	-630,433 Reduced 69.49%	276,802 $1.11 Million
Q2 2020 Aug 14, 2020	BUY	$2.29 - $4.24 $1.27 Million - $2.35 Million	553,460 Added 156.44%	907,235 $3.57 Million
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $601,939 - $1.38 Million	313,510 Added 778.62%	353,775 $867,000
Q4 2019 Feb 14, 2020	SELL	$2.41 - $4.4 $38,111 - $69,581	-15,814 Reduced 28.2%	40,265 $164,000
Q3 2019 Nov 14, 2019	BUY	$2.17 - $3.14 $33,723 - $48,798	15,541 Added 38.34%	56,079 $144,000
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $55,895 - $67,162	22,093 Added 119.78%	40,538 $121,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $393,851 - $585,285	-156,913 Reduced 89.48%	18,445 $0
Q4 2018 Feb 14, 2019	SELL	$1.59 - $2.66 $704,004 - $1.18 Million	-442,770 Reduced 71.63%	175,358 $417,000
Q3 2018 Nov 13, 2018	SELL	$1.59 - $2.42 $263,474 - $401,010	-165,707 Reduced 21.14%	618,128 $0
Q2 2018 Aug 10, 2018	BUY	$2.26 - $4.65 $1.53 Million - $3.14 Million	675,472 Added 623.34%	783,835 $0
Q1 2018 May 11, 2018	BUY	$3.51 - $6.04 $231,874 - $399,008	66,061 Added 156.17%	108,363 $510,000
Q4 2017 Feb 09, 2018	SELL	$3.26 - $4.78 $11,237 - $16,476	-3,447 Reduced 7.53%	42,302 $138,000
Q3 2017 Nov 09, 2017	BUY	$3.48 - $4.44 $159,206 - $203,125	45,749	45,749 $202,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.03M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account